Kentucky Retirement Systems Eli Lilly & CO Transaction History

Kentucky Retirement Systems

$3.35 Billion
Q3 2024

A detailed history of Kentucky Retirement Systems transactions in Eli Lilly & CO stock. As of the latest transaction made, Kentucky Retirement Systems holds 54,956 shares of LLY stock, worth $41.1 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

54,956

Previous 60,160 8.65%

Holding current value

$41.1 Million

Previous $54.5 Million 10.61%

% of portfolio

1.46%

Previous 1.59%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $4.02 Million - $5 Million	-5,204 Reduced 8.65%	54,956 $48.7 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $288,498 - $361,797	-398 Reduced 0.66%	60,160 $54.5 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $1.92 Million - $2.57 Million	-3,244 Reduced 5.08%	60,558 $47.1 Million
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $64,598 - $76,152	-123 Reduced 0.19%	63,802 $37.2 Million
Q3 2023 Oct 12, 2023	BUY	$434.7 - $599.3 $250,387 - $345,196	576 Added 0.91%	63,925 $34.3 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $348,284 - $465,697	993 Added 1.59%	63,349 $29.7 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $109,031 - $128,051	351 Added 0.57%	62,356 $21.4 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $87,140 - $101,535	271 Added 0.44%	62,005 $22.7 Million
Q3 2022 Nov 16, 2022	BUY	$296.48 - $337.87 $949,625 - $1.08 Million	3,203 Added 5.47%	61,734 $20 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $2.21 Million - $2.59 Million	7,923 Added 15.66%	58,531 $19 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $1.65 Million - $2.05 Million	7,029 Added 16.13%	50,608 $14.5 Million
Q4 2021 Feb 04, 2022	SELL	$224.85 - $279.04 $581,237 - $721,318	-2,585 Reduced 5.6%	43,579 $12 Million
Q3 2021 Nov 17, 2021	SELL	$221.6 - $272.71 $41,660 - $51,269	-188 Reduced 0.41%	46,164 $10.7 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $1.4 Million - $1.81 Million	-7,735 Reduced 14.3%	46,352 $10.6 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $1.35 Million - $1.74 Million	8,200 Added 17.87%	54,087 $10.1 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $70,578 - $93,392	-541 Reduced 1.17%	45,887 $7.75 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $66,968 - $77,461	-458 Reduced 0.98%	46,428 $6.87 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $1.48 Million - $1.78 Million	-10,818 Reduced 18.75%	46,886 $7.7 Million
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $1.69 Million - $2.1 Million	14,237 Added 32.75%	57,704 $8.01 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $7,163 - $8,872	-67 Reduced 0.15%	43,467 $5.71 Million
Q3 2019 Nov 05, 2019	BUY	$106.79 - $116.16 $351,979 - $382,863	3,296 Added 8.19%	43,534 $4.87 Million
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $5,650 - $6,595	-51 Reduced 0.13%	40,238 $4.46 Million
Q1 2019 May 22, 2019	SELL	$111.31 - $131.02 $80,254 - $94,465	-721 Reduced 1.76%	40,289 $5.23 Million
Q4 2018 Feb 25, 2019	BUY	$105.9 - $118.64 $32,299 - $36,185	305 Added 0.75%	41,010 $4.75 Million
Q3 2018 Nov 19, 2018	SELL	$85.86 - $107.31 $3.53 Million - $4.42 Million	-41,151 Reduced 50.27%	40,705 $0
Q3 2018 Nov 16, 2018	BUY	$85.86 - $107.31 $3.55 Million - $4.43 Million	41,302 Added 101.84%	81,856 $0
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $738,983 - $848,122	-9,762 Reduced 19.4%	40,554 $3.46 Million
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $699,874 - $826,155	-9,431 Reduced 15.78%	50,316 $3.89 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $10,406 - $11,162	127 Added 0.21%	59,747 $5.05 Million
Q3 2017 Nov 08, 2017	SELL	$77.07 - $85.54 $202,231 - $224,456	-2,624 Reduced 4.22%	59,620 $5.1 Million
Q2 2017 Aug 18, 2017	BUY	N/A	62,244	62,244 $5.12 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.

Account

Kentucky Retirement Systems Eli Lilly & CO Transaction History